188 related articles for article (PubMed ID: 31434704)
21. Utx loss causes myeloid transformation.
Zheng L; Xu L; Xu Q; Yu L; Zhao D; Chen P; Wang W; Wang Y; Han G; Chen CD
Leukemia; 2018 Jun; 32(6):1458-1465. PubMed ID: 29479066
[TBL] [Abstract][Full Text] [Related]
22. RNAi screen identifies Jarid1b as a major regulator of mouse HSC activity.
Cellot S; Hope KJ; Chagraoui J; Sauvageau M; Deneault É; MacRae T; Mayotte N; Wilhelm BT; Landry JR; Ting SB; Krosl J; Humphries K; Thompson A; Sauvageau G
Blood; 2013 Aug; 122(9):1545-55. PubMed ID: 23777767
[TBL] [Abstract][Full Text] [Related]
23. KDM6A, a histone demethylase, regulates stress hematopoiesis and early B-cell differentiation.
Huppertz S; Senger K; Brown A; Leins H; Eiwen K; Mulaw MA; Geiger H; Becker M
Exp Hematol; 2021 Jul; 99():32-43.e13. PubMed ID: 34126175
[TBL] [Abstract][Full Text] [Related]
24. The histone H2A deubiquitinase Usp16 regulates hematopoiesis and hematopoietic stem cell function.
Gu Y; Jones AE; Yang W; Liu S; Dai Q; Liu Y; Swindle CS; Zhou D; Zhang Z; Ryan TM; Townes TM; Klug CA; Chen D; Wang H
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E51-60. PubMed ID: 26699484
[TBL] [Abstract][Full Text] [Related]
25. Advances in histone demethylase KDM4 as cancer therapeutic targets.
Lee DH; Kim GW; Jeon YH; Yoo J; Lee SW; Kwon SH
FASEB J; 2020 Mar; 34(3):3461-3484. PubMed ID: 31961018
[TBL] [Abstract][Full Text] [Related]
26. Dpy30 is critical for maintaining the identity and function of adult hematopoietic stem cells.
Yang Z; Shah K; Khodadadi-Jamayran A; Jiang H
J Exp Med; 2016 Oct; 213(11):2349-2364. PubMed ID: 27647347
[TBL] [Abstract][Full Text] [Related]
27. The JmjN domain as a dimerization interface and a targeted inhibitor of KDM4 demethylase activity.
Levin M; Stark M; Assaraf YG
Oncotarget; 2018 Mar; 9(24):16861-16882. PubMed ID: 29682190
[TBL] [Abstract][Full Text] [Related]
28. ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells.
Garrison BS; Rybak AP; Beerman I; Heesters B; Mercier FE; Scadden DT; Bryder D; Baron R; Rossi DJ
Blood; 2017 Aug; 130(5):619-624. PubMed ID: 28615219
[TBL] [Abstract][Full Text] [Related]
29. KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.
Chin YW; Han SY
Expert Opin Ther Pat; 2015 Feb; 25(2):135-44. PubMed ID: 25468267
[TBL] [Abstract][Full Text] [Related]
30. Histone demethylase LSD1 regulates hematopoietic stem cells homeostasis and protects from death by endotoxic shock.
Wang J; Saijo K; Skola D; Jin C; Ma Q; Merkurjev D; Glass CK; Rosenfeld MG
Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E244-E252. PubMed ID: 29263096
[TBL] [Abstract][Full Text] [Related]
31. Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives.
Westaway SM; Preston AG; Barker MD; Brown F; Brown JA; Campbell M; Chung CW; Diallo H; Douault C; Drewes G; Eagle R; Gordon L; Haslam C; Hayhow TG; Humphreys PG; Joberty G; Katso R; Kruidenier L; Leveridge M; Liddle J; Mosley J; Muelbaier M; Randle R; Rioja I; Rueger A; Seal GA; Sheppard RJ; Singh O; Taylor J; Thomas P; Thomson D; Wilson DM; Lee K; Prinjha RK
J Med Chem; 2016 Feb; 59(4):1357-69. PubMed ID: 26771107
[TBL] [Abstract][Full Text] [Related]
32. Deubiquitinase MYSM1 Is Essential for Normal Fetal Liver Hematopoiesis and for the Maintenance of Hematopoietic Stem Cells in Adult Bone Marrow.
Förster M; Belle JI; Petrov JC; Ryder EJ; Clare S; Nijnik A
Stem Cells Dev; 2015 Aug; 24(16):1865-77. PubMed ID: 26125289
[TBL] [Abstract][Full Text] [Related]
33. Latexin Inactivation Enhances Survival and Long-Term Engraftment of Hematopoietic Stem Cells and Expands the Entire Hematopoietic System in Mice.
Liu Y; Zhang C; Li Z; Wang C; Jia J; Gao T; Hildebrandt G; Zhou D; Bondada S; Ji P; St Clair D; Liu J; Zhan C; Geiger H; Wang S; Liang Y
Stem Cell Reports; 2017 Apr; 8(4):991-1004. PubMed ID: 28330618
[TBL] [Abstract][Full Text] [Related]
34. The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers.
Dorna D; Paluszczak J
Cells; 2022 Mar; 11(6):. PubMed ID: 35326475
[TBL] [Abstract][Full Text] [Related]
35. Structural and evolutionary basis for the dual substrate selectivity of human KDM4 histone demethylase family.
Hillringhaus L; Yue WW; Rose NR; Ng SS; Gileadi C; Loenarz C; Bello SH; Bray JE; Schofield CJ; Oppermann U
J Biol Chem; 2011 Dec; 286(48):41616-41625. PubMed ID: 21914792
[TBL] [Abstract][Full Text] [Related]
36. The nuclear receptor corepressor NCoR1 regulates hematopoiesis and leukemogenesis in vivo.
Wan X; Liu L; Zhou P; Hui X; He Q; Yu F; Zhang W; Ding X; Yuan X; Zhang N; Zhao Y; Zhu R; Liu Y; Hao P; Auwerx J; Song X; Leng Q; Zhang Y
Blood Adv; 2019 Feb; 3(4):644-657. PubMed ID: 30804018
[TBL] [Abstract][Full Text] [Related]
37. UTX maintains the functional integrity of the murine hematopoietic system by globally regulating aging-associated genes.
Sera Y; Nakata Y; Ueda T; Yamasaki N; Koide S; Kobayashi H; Ikeda KI; Kobatake K; Iwasaki M; Oda H; Wolff L; Kanai A; Nagamachi A; Inaba T; Sotomaru Y; Ichinohe T; Koizumi M; Miyakawa Y; Honda ZI; Iwama A; Suda T; Takubo K; Honda H
Blood; 2021 Feb; 137(7):908-922. PubMed ID: 33174606
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of histone deacetylases by Trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival.
Obier N; Uhlemann CF; Müller AM
Cytotherapy; 2010 Nov; 12(7):899-908. PubMed ID: 20210674
[TBL] [Abstract][Full Text] [Related]
39. PRDM16 isoforms differentially regulate normal and leukemic hematopoiesis and inflammatory gene signature.
Corrigan DJ; Luchsinger LL; Justino de Almeida M; Williams LJ; Strikoudis A; Snoeck HW
J Clin Invest; 2018 Aug; 128(8):3250-3264. PubMed ID: 29878897
[TBL] [Abstract][Full Text] [Related]
40. Unraveling KDM4 histone demethylase expression and its association with adverse cytogenetic findings in chronic lymphocytic leukemia.
Filiú-Braga LDC; Serejo TRT; Lucena-Araujo AR; Neves FAR; de Carvalho JL; Rego EM; Saldanha-Araujo F
Med Oncol; 2018 Nov; 36(1):3. PubMed ID: 30426231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
